|Day Low/High||45.08 / 45.30|
|52 Wk Low/High||30.89 / 47.98|
World's biggest diabetes drugmaker sees lower 2018 prices in U.S. markets
Novo Nordisk makes the app available for free
The legislation would also force companies to announce planned price hikes.
Stocks move mostly lower on Thursday after the House passes a bill to repeal and replace the Affordable Care Act.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANH, DVN, EXEL, FMC, FSI, GLT, MEOH, MJCO, MOH, NVO, RPXC, TECH, WU, WWE Downgrades: CIGI, IPHI, QUOT Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
- New combination treatment option for adults with type 2 diabetes now available in pharmacies
U.S. stock futures decline and European shares trade lower following disappointing earnings from Apple and as Wall Street looks to Wednesday's announcement from the Federal Reserve on interest rates.